Literature DB >> 7769308

Monocyte chemotactic protein 1 is released during lethal and sublethal bacteremia in baboons.

P M Jansen1, J van Damme, W Put, I W de Jong, F B Taylor, C E Hack.   

Abstract

The chemokine monocyte chemotactic protein 1 (MCP-1) is a cytokine with chemotactic activity specific for mononuclear phagocytes. To investigate the possible involvement of MCP-1 in the pathogenesis of sepsis, its course was studied in baboons challenged intravenously with a sublethal or lethal dose of Escherichia coli. Levels of MCP-1 started to increase in both groups of animals 2 h after injection of E. coli, reaching peak levels 4 and 6 h after a sublethal (186 +/- 21 ng/mL) or a lethal (213 +/- 24 ng/mL) dose, respectively. Levels of MCP-1 correlated significantly with plasma levels of another chemokine, interleukin-8 (IL-8; r = .826. P < .001), suggesting that common stimuli mediate the release of both cytokines in this model.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769308     DOI: 10.1093/infdis/171.6.1640

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Sequential measurements of chemokines in urosepsis and experimental endotoxemia.

Authors:  D P Olszyna; J M Prins; P E Dekkers; E De Jonge; P Speelman; S J Van Deventer; T Van Der Poll
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

2.  LPS-induced murine systemic inflammation is driven by parenchymal cell activation and exclusively predicted by early MCP-1 plasma levels.

Authors:  Justin E Juskewitch; Bruce E Knudsen; Jeffrey L Platt; Karl A Nath; Keith L Knutson; Gregory J Brunn; Joseph P Grande
Journal:  Am J Pathol       Date:  2011-11-07       Impact factor: 4.307

3.  Distinct functions of interferon-gamma for chemokine expression in models of acute lung inflammation.

Authors:  B Neumann; K Emmanuilidis; M Stadler; B Holzmann
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

4.  MCP-1 protects mice in lethal endotoxemia.

Authors:  D A Zisman; S L Kunkel; R M Strieter; W C Tsai; K Bucknell; J Wilkowski; T J Standiford
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

5.  Monocyte chemoattractant protein 1 does not contribute to protective immunity against pneumococcal pneumonia.

Authors:  Mark C Dessing; Alex F de Vos; Sandrine Florquin; Tom van der Poll
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

6.  Serum MIP-1 alpha and IL-8 in septic patients.

Authors:  S Fujishima; J Sasaki; Y Shinozawa; K Takuma; H Kimura; M Suzuki; M Kanazawa; S Hori; N Aikawa
Journal:  Intensive Care Med       Date:  1996-11       Impact factor: 17.440

Review 7.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

8.  Inhibition of monocyte chemoattractant protein-1 prevents diaphragmatic inflammation and maintains contractile function during endotoxemia.

Authors:  Katherine Labbe; Gawiyou Danialou; Dusanka Gvozdic; Alexandre Demoule; Maziar Divangahi; John H Boyd; Basil J Petrof
Journal:  Crit Care       Date:  2010-10-07       Impact factor: 9.097

Review 9.  Chemokines in acute respiratory distress syndrome.

Authors:  Padmam Puneet; Shabbir Moochhala; Madhav Bhatia
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-01       Impact factor: 5.464

10.  Selected Biomarkers Correlate with the Origin and Severity of Sepsis.

Authors:  Michal Holub; Olga Džupová; Michaela Růžková; Alžběta Stráníková; Eva Bartáková; Jan Máca; Jiří Beneš; Heiko Herwald; Ondřej Beran
Journal:  Mediators Inflamm       Date:  2018-03-27       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.